Oxford BioTherapeutics

Greater London Legal Chronicle. October 28, 2022

Oxford BioTherapeutics’ Global Commercial License Agreement

By Giulia Di Palma

In UK Gowling WLG, advised on the matter. Gowling WLG advised Oxford BioTherapeutics with a team including Patrick Duxbury (Picture – Life Science & Health Care)....

This content is for members only.
Join Now

Already a member? Log in here

Greater London. Greater London Legal Chronicle. June 29, 2022

Oxford BioTherapeutics’ Collaboration With ImmunoGen, Inc.

By Giulia Di Palma

In UK Gowling WLG, advised on the matter. Gowling WLG advised Oxford BioTherapeutics with a team including Patrick Duxbury (Picture – Life Science & Health Care)....

This content is for members only.
Join Now

Already a member? Log in here

Takko Fashion GmbH’s €553 Million Refinancing

TotalEnergies’ Divestment Of 50% Stake In West Burton B

Orbus Software Group’s Acquisition of Capsifi

FirstGroup’s Acquisition Of RATP London

Kirkland Advises Blackstone on $1.5 Billion Investment in KKR

The Walt Disney Company’s $500 Million Senior Notes Offering

Cicada Solar Limited’s $10 Million Financing Round

Coigach Community Development Company’s Acquisition Of 7,900 Acres Of Tenanted Croft Land And Common Grazings

Robert P. Slight & Sons’ Sale to EOT

Gyrus Capital’s €600 Million Continuation Fund

RoundShield’s Closing of Private Credit Fund RS Fund V

Deep Blue’s Launch of the First Stablecoin of DBUSD in Jersey

Stevens & Bolton Bolsters Corporate Tax Practice With Lateral Hire

Charles Russell Speechlys Announces the Opening of a New Office in Italy

TLT Appoints Madi Dacwy as a Partner In Its Projects, Infrastructure and Construction Team

Oxford BioTherapeutics’ Global Commercial License Agreement

Oxford BioTherapeutics’ Collaboration With ImmunoGen, Inc.